The effects of either single injection or continuous infusion of synthetic Gn-RH on plasma hCG levels were studied in 5 pregnant women (14-38 week gestation). No definite increase of hCG level was seen in all the cases studied. In view of large dosages of Gn-RH used in this study in comparison with its minimum effective dose for the pituitary gonadotropin release, Gn-RH seems unlikely to play a role in hCG secretion during human pregnancy.
The levels of human chorionic gonadotropin (hCG), in either plasma or urine, are widely believed to show unique changes throughout pregnancy, which increases drastically from 10 to 11 days after ovulation, remains high for the next several weeks, and then declines after 14-15 week gestation. Such changes in hCG level are in marked contrast to the other placental hormones, such as steroids and human chorionic somatomammotropin (hCS), which increase as pregnancy progresses.
Little is, however, known about the mechanism to control hCG secretion from the placenta. The role of Gn-RH is not known in the control mechanism of hCG secretion in contrast to the established role of Gn-RH in gonadotropin secretion from the pituitary.
Concerning the relationships between Gn-RH and placental function, only a few papers have appeared till today. Takagi (1971) (Ryes et al., 1976) .
Results
The changes of plasma hCG level following a single injection are shown in Fig. 2 , and those following infusion in Fig. 3 Gn-RH 100ƒÊg Fig. 1 . Release of pituitary FSH and LH during and following infusion and single bolus of Gn-RH in the follicular phase of normal cyclic women. The speed of Gn-RH infusion is indicated per hr in the upper square.
Except in case 1, both LH and FSH increase 2 to 5 hr after starting infusion, which is compatible with the peak value at the normal ovulatory period. Positive response to Gn-RH single injection seen in case 1, indicates that the woman is not abnormal.
women, no comments were made on the effect of Gn-RH on hCG levels.
From the present data, it is strongly suggested that Gn-RH seems unlikely to play a role in hCG secretion during human pregnancy.
In addition, radioimmunoassay of Gn-RH in our laboratory failed to reveal detectable activity in the rat placenta, maternal plasma and human amniotic fluid while the rat hypothalamus was shown to have 3.01ng per hypothalamus by the same assay.
There might be, however, a possibility that a fetal organ and/or placenta produces Gn-RH, and enormous high concentration of Gn-RH is kept in the placenta and stimulates it to secrete hCG.
Further studies will be needed to examine the possibility. 
